COMMUNIQUÉS West-GlobeNewswire

Minerva Neurosciences Elects William Doyle and Hans Peter Hasler to Board of Directors

11/12/2017 - 14:15

WALTHAM, Mass., Dec. 11, 2017 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV ), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) [...]

Restoration Robotics® Announces Appointment of Mark Hair as Chief Financial Officer

11/12/2017 - 14:01

SAN JOSE, Calif., Dec. 11, 2017 (GLOBE NEWSWIRE) -- Restoration Robotics, Inc. (NASDAQ: HAIR ), announced today that Mark L. Hair will join the Company as Chief Financial Officer, effective January 5, 2018. Mr. Hair [...]

Altimmune Submits Investigational New Drug Application for NasoShield in Preparation for its Phase 1 Trial

11/12/2017 - 14:00

145 Patients to be enrolled Data expected in the second quarter of 2018 Study will be fully-funded by BARDA GAITHERSBURG, Md., Dec. 11, 2017 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT ), a clinical-stage [...]

TeneoBio’s Next Gen Multivalent anti-BCMAxCD3, TNB-383B, and Anti-BCMA UniDabs for CAR T-Cell Therapy of Multiple Myeloma Highlighted at the American Society of Hematology

11/12/2017 - 14:00

MENLO PARK, Calif., Dec. 11, 2017 (GLOBE NEWSWIRE) -- TeneoBio, Inc. yesterday presented preclinical data on its lead therapeutic candidate, TNB-383B, a multivalent anti-BCMAxCD3 at the American Society of Hematology [...]

Multiple Programs Featuring Poseida Therapeutics’ Advanced CAR-T Therapies Presented at American Society of Hematology 2017 Annual Meeting

11/12/2017 - 14:00

SAN DIEGO, Dec. 11, 2017 (GLOBE NEWSWIRE) -- Poseida Therapeutics Inc. (“Poseida”), a San Diego-based company translating best-in-class gene engineering technologies into lifesaving cell therapies, today announced [...]

Inovio Pharmaceuticals Promotes Dr. Laurent Humeau to Senior Vice President, Research & Development

11/12/2017 - 14:00

PLYMOUTH MEETING, Pa., Dec. 11, 2017 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO ) has promoted Dr. Laurent Humeau to Senior Vice President, Research & Development, reporting to Dr. J. Joseph Kim, [...]

HempAmericana Commences Distributor Agreement Negotiations with Major CBD Oil Distributors

11/12/2017 - 14:00

NEW YORK, Dec. 11, 2017 (GLOBE NEWSWIRE) -- HempAmericana, Inc. (OTC:HMPQ) (the “Company”) is excited to announce it has begun negotiations with high-volume CBD Oil distributors around the country. The company is [...]

Yield10 Bioscience Grants Research License to Monsanto to Evaluate Two Novel Yield Traits in Soybean

11/12/2017 - 14:00

WOBURN, Mass., Dec. 11, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ: YTEN ) announced today that it has granted a non-exclusive research license to Monsanto Company to evaluate its novel C3003 and C3004 [...]

Catalyst Biosciences Announces Interim Phase 1/2 CB 2679d/ISU304 Results at the American Society of Hematology Conference

11/12/2017 - 14:00

Subcutaneous (SQ) delivery significantly increases half-life of CB 2679d to 98.7 hours Data supports potential normalization of FIX activity with daily or less-frequent SQ dosing SOUTH SAN FRANCISCO, Calif., Dec. 11, [...]

Samumed Doses First Patient in Phase 1 Trial of SM08502 for Treatment of Advanced Solid Tumors

11/12/2017 - 14:00

SAN DIEGO, Dec. 11, 2017 (GLOBE NEWSWIRE) -- Samumed, LLC, today announced the dosing of the first cancer patient in its Phase 1 trial of SM08502, a small molecule Wnt pathway inhibitor in oral tablet formulation. This [...]

Caelum Biosciences Announces Positive Phase 1a/1b Data Demonstrating CAEL-101 (mAb 11-1F4) Improves Organ Function in AL Amyloidosis

11/12/2017 - 14:00

Eight of 12 patients (67 percent) with cardiac involvement responded to therapy with a median time to cardiac response of 21 days 14 of 24 (63 percent) of patients demonstrated organ response CAEL-101 dosed once weekly [...]

Vital Therapies Added to NASDAQ Biotechnology Index

11/12/2017 - 14:00

SAN DIEGO, Dec. 11, 2017 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq: VTL ), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver failure, today announced [...]

Spark Therapeutics Presents Preliminary Data on Investigational SPK-8011 Phase 1/2 Dose-escalation Clinical Trial in Hemophilia A at 59th American Society of Hematology (ASH) Annual Meeting and Exposition

11/12/2017 - 13:45

PHILADELPHIA, Dec. 11, 2017 (GLOBE NEWSWIRE) -- Spark Therapeutics (NASDAQ: ONCE ), a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, today announced that it has [...]

Epizyme Presents Preclinical Data on Novel G9a Program and Introduces Next Drug Development Candidate at the American Society of Hematology Annual Meeting

11/12/2017 - 13:31

CAMBRIDGE, Mass., Dec. 11, 2017 (GLOBE NEWSWIRE) -- Epizyme, Inc. (NASDAQ: EPZM ), a clinical-stage company developing novel epigenetic therapies, announced today new preclinical data from its novel G9a program for [...]

Alimera Sciences Announces Patients Now Being Treated With ILUVIEN® In Ireland

11/12/2017 - 13:30

ATLANTA, Dec. 11, 2017 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (NASDAQ: ALIM ) (Alimera), a leader in the commercialization and development of prescription ophthalmic pharmaceuticals, today announced that the first [...]

Mucodel Pharma LLC Announces Successful Completion of Clinical Study of its Co-Gel Intranasal Naloxone Formulation

11/12/2017 - 13:30

Greensboro, NC, Dec. 11, 2017 (GLOBE NEWSWIRE) -- Mucodel Pharma LLC (“Mucodel”) today announced the successful completion of a pilot clinical study involving intranasal naloxone, a Mucodel product under development for [...]

SIGA Technologies Announces FDA Submission of its New Drug Application for oral TPOXX (tecovirimat) to Treat Smallpox

11/12/2017 - 13:30

– Company requests Priority Review of TPOXX NDA – – If approved, would be the first treatment for deadly smallpox – NEW YORK, Dec. 11, 2017 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (OTCMKTS:SIGA), a health [...]

Cancer Genetics advances understanding of immune response and measurement in lymphomas by combining PD-L1 expression analysis with RNA analysis

11/12/2017 - 13:30

Study Presented at the 59 th American Society of Hematology (ASH) Annual Meeting Study focused on DLBCL (Diffuse Large B-Cell Lymphomas) RUTHERFORD, N.J., Dec. 11, 2017 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq [...]

Reata Pharmaceuticals, Inc. Presents Interim Phase 1b Data for Omaveloxolone in the Treatment of Unresectable or Metastatic Melanoma

11/12/2017 - 13:30

IRVING, Texas, Dec. 11, 2017 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq: RETA ) (“Reata” or “the Company”), a clinical-stage biopharmaceutical company, today announced the presentation of interim data from [...]